Frontline TKI in Intermediate-Risk Renal Cell Carcinoma
EP. 1: Case-Based Overview: Newly Diagnosed Renal Cell Carcinoma
December 18th 2019
EP. 2: CABOSUN Trial: Cabozantinib vs Sunitinib for Renal Cell Carcinoma
December 18th 2019
EP. 3: RCC: Treating Autoimmune Patients with Cabozantinib Versus Immunotherapy
December 18th 2019
EP. 4: Factors Considered When Choosing RCC Treatment Options
December 18th 2019
EP. 5: MOA and Management of Any Adverse Effects of Cabozantinib
December 18th 2019
EP. 6: Other Trials and Combinations to Treat Renal Cell Carcinoma
December 18th 2019
